The Europe bioresorbable polymers is estimated at USD 17239.94 million in 2024 and is projected to reach USD 33296.06 million by 2029 growing at CAGR of 14.07% during the forecast period 2024 to 2029.
One of the major factors driving the European bioresorbable polymers market is the increase in patient comfort brought about by bioresorbable polymers. In case of conventional materials, they are left in the body post-surgery which require another minor surgery to remove the materials, some presenting a health risks to the patient. Further, the growing demand for bioresorbable polymers for drug delivery is another key aspect boosting the growth of bioresorbable polymers market in European countries. The chemically neutral nature of bioresorbable polymers and their harmless decomposition in the body make them perfect for drug delivery.However, due to employment of advanced technology, bioresorbable polymers cost more than conventional medical polymers which is limiting its reach to people Central and Eastern European countries along with the lack of advanced healthcare infrastructure.
Agro-polymers (Polysaccharides, Proteins), Biopolyesters (polylactic acid, Polyglycolic Acid, Polycaprolactone and others)
Orthopaedics, Drug Delivery and others.
France, Italy, Germany, Spain and UK
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region